Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study results
Titel:
Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study results
Auteur:
Pavel, Marianne Ćwikła, Jaroslaw B. Lombard-Bohas, Catherine Borbath, Ivan Shah, Tahir Pape, Ulrich F. Capdevila, Jaume Panzuto, Francesco Truong Thanh, Xuan-Mai Houchard, Aude Ruszniewski, Philippe